Akari Therapeutics PLC (AKTX)
1.28
-0.19
(-12.93%)
USD |
NASDAQ |
Nov 21, 16:00
1.28
0.00 (0.00%)
After-Hours: 19:10
Akari Therapeutics Price: 1.28 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 1.68 | 1.68 | 1.46 | 1.47 | 85317.00 |
Nov 19, 2024 | 2.45 | 2.45 | 1.49 | 1.57 | 317578.0 |
Nov 18, 2024 | 2.20 | 2.330 | 2.20 | 2.29 | 19940.00 |
Nov 15, 2024 | 2.17 | 2.17 | 1.77 | 2.08 | 19448.00 |
Nov 14, 2024 | 2.40 | 2.40 | 2.23 | 2.23 | 5644.00 |
Nov 13, 2024 | 2.23 | 2.391 | 2.23 | 2.24 | 5517.00 |
Nov 12, 2024 | 2.283 | 2.30 | 2.25 | 2.30 | 1958.00 |
Nov 11, 2024 | 2.32 | 2.38 | 2.206 | 2.30 | 12504.00 |
Nov 08, 2024 | 2.523 | 2.563 | 2.28 | 2.45 | 20611.00 |
Nov 07, 2024 | 2.28 | 2.43 | 2.28 | 2.43 | 2076.00 |
Nov 06, 2024 | 2.43 | 2.43 | 2.21 | 2.315 | 9697.00 |
Nov 05, 2024 | 2.39 | 2.50 | 2.22 | 2.43 | 39553.00 |
Nov 04, 2024 | 2.91 | 2.91 | 2.20 | 2.429 | 50984.00 |
Nov 01, 2024 | 2.537 | 3.15 | 2.43 | 2.78 | 47292.00 |
Oct 31, 2024 | 2.44 | 2.57 | 2.40 | 2.40 | 4439.00 |
Oct 30, 2024 | 2.58 | 2.58 | 2.318 | 2.41 | 12123.00 |
Oct 29, 2024 | 2.47 | 2.50 | 2.359 | 2.50 | 25731.00 |
Oct 28, 2024 | 2.30 | 2.49 | 2.30 | 2.40 | 2296.00 |
Oct 25, 2024 | 2.258 | 2.50 | 2.25 | 2.364 | 12499.00 |
Oct 24, 2024 | 2.25 | 2.440 | 2.205 | 2.27 | 17509.00 |
Oct 23, 2024 | 2.13 | 2.21 | 2.13 | 2.21 | 1940.00 |
Oct 22, 2024 | 2.23 | 2.25 | 2.10 | 2.133 | 11160.00 |
Oct 21, 2024 | 2.23 | 2.326 | 2.14 | 2.16 | 8912.00 |
Oct 18, 2024 | 2.26 | 2.49 | 2.222 | 2.24 | 8488.00 |
Oct 17, 2024 | 2.44 | 2.485 | 2.20 | 2.21 | 9335.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.10
Minimum
Apr 11 2024
77.60
Maximum
Feb 19 2021
21.50
Average
22.95
Median
Price Benchmarks
DBV Technologies SA | 0.485 |
Cellectis SA | 1.88 |
Adaptimmune Therapeutics PLC | 0.634 |
Biodexa Pharmaceuticals PLC | 4.36 |
NuCana PLC | 1.27 |
Price Related Metrics
Earnings Yield | -168.5% |
Market Cap | 15.30M |